Skip to main content
. Author manuscript; available in PMC: 2021 Jun 4.
Published in final edited form as: World J Urol. 2018 May 2;36(10):1621–1627. doi: 10.1007/s00345-018-2299-2

Table 2.

Pathology at re-TUR according to the presence or absence of muscle in the specimen of first TUR.

Variable No Muscle at first TUR, N (%) Muscle at first TUR, N (%) Muscle at first TUR unknown, N (%) All patients

Patients 276 624 35 935

Pathology at re-TUR*
No residual tumour 39 (14.1) 217 (34.8) 11 (31.4) 267 (28.6)
Ta 126 (45.7) 240 (38.5) 12 (34.3) 378 (40.4)
T1 111 (40.2) 166 (26.6) 12 (34.3) 289 (30.9)
CIS NA** NA** NA** NA**
Missing/unknown 0 1 (.02) 0 1 (0.1)
**

Separate information on CIS at re-TUR was not available.